Oleic acid content is responsible for the reduction in blood pressure induced by olive oil

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 37, 2008, Pages 13811-13816

  Teres S ^a   Barcelo Coblijn G ^a   Benet, M ^a   Alvarez R ^a   Bressani, R ^b   Halver, J E ^c   Escriba P V ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b Rural University of Guatemala   (Guatemala)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Aorta; Fatty acids; Membrane structure; Membrane lipid therapy; Signaling proteins

Indexed keywords

ADENYLATE CYCLASE; ELAIDIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE LIPID; OLEIC ACID; OLIVE OIL; PHOSPHOLIPASE C; SOYBEAN OIL; STEARIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA; BLOOD PRESSURE; FEMALE; HEART RATE; HYPERTENSION; OLEIC ACID; PLANT OILS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SOYBEAN OIL; STEARIC ACIDS;

GLYCINE MAX;

EID: 52949091533     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0807500105     Document Type: Article

References (46)

1. Yang Q, et al. (2005) Influence of the membrane lipid structure on signal processing via G protein-coupled receptors. Mol Pharmacol 68:210-217.
2. Funari SS, Barceló F, Escribá PV (2003) Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes. J Lipid Res 44:567-575.
3. Prades J, Funari SS, Escribá PV, Barceló, F (2003) Effects of unsaturated fatty acids and triacylglycerols on phosphatidylethanolamine membrane structure. J Lipid Res 44:1720-1727.
4. Barceló, F, et al. (2004) The hypotensive drug 2-hydroxyoleic acid modifies the structural properties of model membranes. Mol Membr Biol 21:261-268.
5. Martínez J, et al. (2005) Membrane structure modulation, protein kinase Cα activation, and anticancer activity of minerval. Mol Pharmacol 67:531-540.
6. Menotti A, et al. (1990) Twenty-five-year mortality from coronary heart disease and its prediction in five cohorts of middle-aged men in Finland, The Netherlands, and Italy. Prev Med 19:270-278.
7. Martínez-González MA, Sánchez-Villegas A (2004) The emerging role of Mediterranean diets in cardiovascular epidemiology: Monounsaturated fats, olive oil, red wine, or the whole pattern? Eur J Epidemiol 19:9-13.
8. Zambon D, et al. (2000) Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women:Arandomized cross-over trial. Ann Intern Med 132:538-546.
9. Bemelmans WJ, et al. (2002) Effect of an increased intake of α-linolenic acid and group nutritional education on cardiovascular risk factors: The Mediterranean α-Linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr 75:221-227.
10. Psaltopoulou T, et al. (2004) Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 80:1012-1018.
11. Fuentes F, et al. (2001) Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med 134:1115-1119.
12. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study. J Am Coll Cardiol 44:152-158.
13. Alonso A, Martínez-González MA (2004) Olive oil consumption and reduced incidence of hypertension: The SUN study. Lipids 39:1233-1238.
14. Estruch R, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: A randomized trial. Ann Intern Med 145:1-11.
15. Perona JS, et al. (2007) Consumption of virgin olive oil influences membrane lipid composition and regulates intracellular signaling in elderly adults with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 62:256-263.
16. Ruiz-Gutiérrez V, Muriana FJ, Guerrero A, Cert AM, Villar J (1996) Plasma lipids, erythrocyte membrane lipids, and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J Hypertens 14:1483-1490.
17. Alemany R, et al. (2007) G protein-coupled receptor systems and their lipid environment in health disorders during aging. Biochim Biophys Acta 1768:964-975.
18. Alemany R, et al. (2004) 2-Hydroxyoleic acid: A new hypotensive molecule. Hypertension 43:249-254.
19. Alemany R, et al. (2006) Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase A pathway and Rho kinase. J Lipid Res 47:1762-1770.
20. Visioli F, Galli C (2001) Antiatherogenic components of olive oil. Curr Atheroscler Rep 3:64-67.
21. Beauchamp GK, et al. (2005) Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil. Nature 437:45-46.
22. Ferrara LA, et al. (2000) Olive oil and reduced need for antihypertensive medications. Arch Intern Med 160:837-842.
23. Rodriguez-Rodriguez R, Herrera MD, de Sotomayor MA, Ruiz-Gutiérrez V (2007) Pomace olive oil improves endothelial function in spontaneously hypertensive rats by increasing endothelial nitric oxide synthase expression. Am J Hypertens 20:728-734.
24. Escribá, PV, Wedegaertner PB, Goñi FM, Vögler O (2007) Lipid-protein interactions in GPCR-associated signaling. Biochim Biophys Acta 1768:836-852.
25. Vögler O, et al. (2004) The Gβγ dimer drives the interaction of heterotrimeric Gi proteins with nonlamellar membrane structures. J Biol Chem 279:36540-36545.
26. Feldman RD, Chorazyczewski J (1997) G-protein function is reduced in hypertension. Hypertension 29:422-427.
27. Escribá, PV, Sánchez-Domínguez JM, Alemany R, Perona JS, Ruiz-Gutiérrez V (2003) Alteration of lipids, G proteins, and PKC in cell membranes of elderly hypertensives. Hypertension 41:176-182.
28. Clark CJ, Milligan G, McLellan AR, Connell JM (1992) Guanine nucleotide regulatory protein levels and function in spontaneously hypertensive rat vascular smooth-muscle cells. Biochim Biophys Acta 1136:290-296.
29. Marcil J, de Champlain J, Anand-Srivastava MB (1998) Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: Relationship with adenylyl cyclase. Cardiovasc Res 39:492-505.
30. Anand-Srivastava, MB (1992) Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats. Relationship to adenylate cyclase inhibition. Biochem J 288:79-85.
31. Heyden S, Kluthe R, Immenhofer C (1994) International symposium on sodium and hypertension: Results of randomized trials. Clin Invest 72:800-803.
32. Mata P, et al. (1992) Effect of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women. Am J Clin Nutr 56:77-83.
33. Israelachvili JN, Marcelja S, Horn RG (1980) Physical principles of membrane organization. Q Rev Biophys 13:121-200.
34. Lehtonen JY, Holopainen JM, Kinnunen PK (1996) Evidence for the formation of microdomains in liquid crystalline large unilamellar vesicles caused by hydrophobic mismatch of the constituent phospholipids. Biophys J 70:1753-1760.
35. Kinnunen PKJ (1996) On the molecular level mechanisms of peripheral protein-membrane interactions induced by lipids forming inverted nonlamellar phases. Chem Phys Lipids 81:151-166.
36. Pérez FR, Piñeiro V, De La Cruz LF, Casanueva FF, Casabiell X (2003) Vascular wall: potential target for the physicochemical effects of cis-unsaturated free fatty acids. Microsc Res Tech 60:23-29.
37. Casabiell, X, Pandiella A, Casanueva, FF (1991) Regulation of epidermal-growth-factor-receptor signal transduction by cis-unsaturated fatty acids: Evidence for a protein kinase C-independent mechanism. Biochem J 278:679-687.
38. Werstiuk ES, Lee RM (2000) Vascular β-adrenoceptor function in hypertension and in aging. Can J Physiol Pharmacol 78:433-452.
39. Webb JG, Yates PW, Yang Q, Mukhin YV, Lanier SM (2001) Adenylyl cyclase isoforms and signal integration in models of vascular smooth muscle cells. Am J Physiol 281:H1545-H1552.
40. Di Fusco F, Anand-Srivastava MB (2000) Enhanced expression of Gi proteins in nonhypertrophic hearts from rats with hypertension-induced by L-NAME treatment. J Hypertens 18:1081-1090.
41. Li Y, Anand-Srivastava MB (2002) Inactivation of enhanced expression of G(i) proteins by pertussis toxin attenuates the development of high blood pressure in spontaneously hypertensive rats. Circ Res 91:247-254.
42. 2+]i transient and contractility in a region-dependent manner. Am J Physiol 294:H1948-H1955.
43. Escribá, PV (2006) Membrane-lipid therapy: A new approach in molecular medicine. Trends Mol Med 12:34-43.
44. Pfeffer JM, Pfeffer MA, Frohlich ED (1971) Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 78:957-962.
45. Escribá, PV, Sastre M, García-Sevilla JA (1994) Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts. Arch Gen Psychiatry 51:494-501.
46. EscribáPV, Morales P, Smith A (2002) Membrane phospholipid reorganization differentially regulates metallothionein and heme oxygenase by heme-hemopexin. DNA Cell Biol 21:355-364.